Hypothalamic orexin/hypocretin (orx/hcrt) neurons regulate energy balance, wakefulness, and reward; their loss produces narcolepsy and weight gain. Glucose can lower the activity of orx/hcrt cells, but whether other dietary macronutrients have similar effects is unclear. We show that orx/hcrt cells are stimulated by nutritionally relevant mixtures of amino acids (AAs), both in brain slice patch-clamp experiments, and in c-Fos expression assays following central or peripheral administration of AAs to mice in vivo. Physiological mixtures of AAs electrically excited orx/hcrt cells through a dual mechanism involving inhibition of K ATP channels and activation of system-A amino acid transporters. Nonessential AAs were more potent in activating orx/hcrt cells than essential AAs. Moreover, the presence of physiological concentrations of AAs suppressed the glucose responses of orx/hcrt cells. These results suggest a new mechanism of hypothalamic integration of macronutrient signals and imply that orx/ hcrt cells sense macronutrient balance, rather than net energy value, in extracellular fluid.
INTRODUCTION
Animal and human health depends on detection of changes in body energy levels by neural circuits coordinating appropriate adaptive responses. A typical change in energy levels comes from meals composed of macronutrient mixtures that are consumed either simultaneously or in a sequence. The nutritional composition of meals, e.g., protein:carbohydrate ratio, has long been recognized to affect the levels of arousal and attention (Spring et al., 1987; Fischer et al., 2002) . However, while certain specialized neurons are known to sense individual nutrients such as glucose (Levin et al., 2004) , it remains unclear how typical dietary combinations of nutrients affect energy balance-regulating neurocircuits.
The central orexin/hypocretin (orx/hcrt) network is critical for regulating arousal, feeding, reward-seeking, and autonomic function (de Lecea et al., 2006; Sakurai, 2007; Kuwaki, 2011) . Orexins/hypocretins are peptide transmitters that in mammalian brains are produced exclusively by a small group of cells located in the lateral hypothalamic area Sakurai et al., 1998) . From this restricted location, orx/hcrt neurons project widely to innervate most of the brain, with major inputs to arousal and reward centers, where orx/hcrt peptides are released and act on two specific G protein-coupled receptors (Sakurai et al., 1998; Peyron et al., 1998) . The firing of orx/ hcrt neurons promotes wakefulness (Adamantidis et al., 2007) and is so critical for sustaining normal consciousness that loss of orx/hcrt cells causes narcolepsy (Hara et al., 2001; Nishino et al., 2000; Thannickal et al., 2000) . Orx/hcrt cells are also thought to stimulate feeding and reward-seeking behavior (Boutrel et al., 2005; Harris et al., 2005; Sakurai et al., 1998) , while their destruction inhibits fasting-induced foraging in mice (Mieda et al., 2004; Yamanaka et al., 2003) . Furthermore, orx/hcrt signaling is involved in autonomic function and peripheral energy balance (reviewed in Karnani and Burdakov, 2011; Kuwaki, 2011) , and both patients with narcolepsy and mice with experimentally destroyed orx/hcrt cells have significantly increased body weights (Hara et al., 2001; Nishino et al., 2001) .
Orx/hcrt neurons are thought to form a dynamic link between these vital functions and body energy status, for example, by exhibiting specialized inhibitory responses to key indicators of energy levels such as glucose and leptin (Diano et al., 2003; Williams et al., 2008; Yamanaka et al., 2003) . However, it remains unknown how their sensing capabilities extend to the other major macronutrients, such as amino acids (AAs) and fatty acids (FAs), or to typical dietary mixtures of macronutrients. Studies correlating transmitter release with changes in dietary intake of protein suggest that the lateral hypothalamus and medial hypothalamus show different responses to protein diets (White et al., 2003) , but the cellular mechanisms are unknown. At the molecular level, hypothalamic AA sensing has been proposed to involve enzymes such as the mammalian target of rapamycin (mTOR) (Cota et al., 2006) , but the importance of this pathway in regulating the activity of orx/hcrt neurons is not understood. In turn, although hypothalamic FA sensing is thought to be critical for normal energy balance (Lam et al., 2005) , the actions of FAs on orx/hcrt cells remain unclear.
Here, we examine the responses of identified orx/hcrt cells to physiological mixtures of macronutrients. We demonstrate that orx/hcrt neurons exhibit novel excitatory responses to physiologically and nutritionally relevant mixtures of AAs, both in reduced brain-slice preparations, and during peripheral or central administration of AAs to mice in vivo. We determine the cellular mechanisms contributing to these unexpected responses. Furthermore, we show that the glucose and AA signals are integrated nonlinearly in favor of AA-induced excitation. In contrast, we did not find evidence that FAs directly regulate the firing of orx/hcrt cells. Our data suggest a new nutrient-specific model for dietary regulation of orx/hcrt neurons.
RESULTS

Nutritionally Relevant Mixes of Amino Acids Excite orx/hcrt Neurons In Situ
To test whether the activity of orx/hcrt cells is modulated by dietary amino acids (AAs), we first used a mixture of amino acids (''AA mix''; see Table S1 available online) based on microdialysis samples from the rat hypothalamus (Choi et al., 1999) . Wholecell patch-clamp recording showed that orx/hcrt cells depolarized and increased their firing frequency in response to the AA mix ( Figure 1A ; all statistics are given in the figure legends unless stated otherwise). The latency of response onset was 66 ± 5 s (n = 25). This response was unaffected by blockers of ionotropic glutamate, GABA, and glycine receptors ( Figure 1B ), or by blockade of spike-dependent synaptic transmission with tetrodotoxin ( Figure 1C ). We did not observe such AA responses in neighboring lateral hypothalamic GAD65 neurons (Figures 1D and 1F; see Experimental Procedures) , or in cortical pyramidal cells (Figures 1E and 1F) .
We also tested whether orx/hcrt cells are modulated by transitions between different physiological levels of AAs. For this, we used a mixture of AAs with approximately 56% lower total concentration than the AA mix above (''low AA'', see Table S1 ), which was also based on microdialysis samples from rat brain (Currie et al., 1995) . By itself, switching from zero AA to the low AA solution induced a depolarization of 8.7 ± 0.4 mV (n = 6, p < 0.02). Switching between low and control AA levels robustly and reversibly altered the membrane potential and firing of orx/hcrt cells (6.1 ± 1.2 mV depolarization, n = 8, p < 0.01, Figure 1G) . Measuring the dose-response relationship of AAinduced excitation of orx/hcrt cells revealed steep sensitivity within the physiological range of AA levels ( Figure 1G ). In addition to whole-cell recordings, we also observed reliable stimulation of orx/hcrt cell firing by physiological AA concentrations using the noninvasive cell-attached recording configuration (Figure 1H) , further demonstrating that it is a robust physiological phenomenon.
Activation of orx/hcrt Cells after Gavage of Amino Acids In Vivo
Previous data in rats show that gavage of a nutritionally relevant AA mix causes an increase in AA concentrations in the lateral hypothalamus, which becomes apparent 20-40 min after gavage and may persist for several hours (Choi et al., 1999) . To test whether such peripheral administration of AAs can activate orx/hcrt neurons in vivo, we intragastrically gavaged mice with an AA mixture that mimics the composition of egg-white albumin (based on Choi et al., 1999) , or with the same volume of vehicle (deionized water), and looked at changes in c-Fos expression in immunohistochemically identified orx/hcrt neurons 3 hr later (see Experimental Procedures). The number of c-Fospositive orx/hcrt neurons in AA-gavaged animals was significantly greater than in vehicle-gavaged animals (Figures 2A and 2B) , consistent with the data showing that gavaged AAs reach the lateral hypothalamus (Choi et al., 1999) , and activate orx/ hcrt cells (Figure 1) .
We also tested whether the AA gavage can produce behavioral effects associated with activation of the orx/hcrt system. Based on previous reports that orx/hcrt promotes locomotor activity (Hagan et al., 1999) , we used locomotion (beam-breaks, see Experimental Procedures) as a behavioral readout of orx/ hcrt tone. Note that the procedures necessary for this experiment (prefasting and gavage) are themselves expected to stimulate orx/hcrt receptors (see Experimental Procedures). Thus, to avoid confounding ''ceiling'' effects, the competitive orx/hcrt receptor antagonist SB-334867 was given simultaneously with gavage (see Experimental Procedures and Figure S1 for full considerations and experimental details). Indeed, in the absence of SB-334867, gavage composition did not significantly affect locomotor activity, likely attributed to a ceiling effect (see Experimental Procedures and Figure S1 ). However, when the background occupancy of orx/hcrt receptors was lowered with SB-334867, AA gavage (but not vehicle gavage) significantly increased locomotor activity and accelerated recovery from the antagonist-induced depression of locomotion (Figures 2C and 2D) . This is consistent with the idea that the activation of orx/hcrt cells by AA gavage (Figures 2A and 2B ) increases orx/hcrt release and thereby displaces the competitive antagonist from orx/hcrt receptors, while in vehicle-gavaged animals, this additional orx/hcrt release is absent, allowing the antagonist to depress locomotion for longer. The AA-induced increase in locomotor activity was transient (see Figures 2C and 2D ), consistent with the transient [AA] elevation resulting from AA gavage (Choi et al., 1999) , and with the reversible nature of AA effects on orx/hcrt cells (Figure 1 ).
Effects of Individual Amino Acids
To explore whether orx/hcrt cells are more sensitive to particular AAs, we first examined their membrane current responses to individual AAs applied at high concentration (5 mM). In this voltage-clamp assay, nonessential AAs elicited large responses, with a relative potency order glycine > aspartate > cysteine > alanine > serine > asparagine > proline > glutamine, while essential AAs were much less effective ( Figures 3A and 3B ). Because leucine has been suggested previously to be sensed in the hypothalamus (Cota et al., 2006) , we investigated its effect across a broad concentration range in comparison with alanine ( Figure 3C ). Across all concentrations tested, leucine (0.02-10 mM) did not induce any detectable membrane currents, whereas alanine dose-dependently stimulated currents with an EC 50 of 3.19 mM ( Figure 3C ). Table S1 ) on orx/hcrt cells (n = 25). Membrane potential during AA application (À39.4 ± 0.8 mV) was higher than preapplication (À51.8 ± 0.6 mV, p < 0.0001) or postapplication (À51.0 ± 1.1 mV, p < 0.0001). (B) Same with synaptic blockers (see Experimental Procedures, n = 5). Membrane potential during AA application (À40.1 ± 1.1 mV) was depolarized relative to preapplication (À50.4 ± 0.5 mV, p < 0.002) or postapplication (À48.0 ± 1.6 mV, p < 0.02). (C) Same as A with tetrodotoxin (0.5 mM, n = 5). Membrane potential during AA application (À42.2 ± 1.4 mV) was higher than preapplication (À53.5 ± 0.8 mV, p < 0.002) or postapplication (À51.2 ± 1.0 mV, p < 0.001).
Neuron
Hypothalamic Integration of Macronutrient Signals
To compare the potencies of essential and nonessential AAs under more physiological conditions, we performed two further experiments. First, we examined membrane potential effects of low concentrations of different AA mixtures. When we mixed AAs together at 100 mM each, and examined their effects in the absence of synaptic blockers (some AAs were omitted to avoid activation of synaptic receptors, see Experimental Procedures), we found that nonessential AA mix induced larger depolarization that essential AA mix ( Figure 3D ). When the AAs were instead mixed together at physiological concentrations measured in the brain (''AA mix'', Table S1 ), and their effects examined in synaptic blockers, the nonessential AA mix also produced greater responses ( Figure 3D ). Second, we infused 5 mM leucine (essential), 5 mM asparagine (nonessential), or vehicle into the lateral hypothalamus of live mice, and examined c-Fos expression in orx/hcrt cells an hour later (see Experimental Procedures). Consistent with in vitro data, asparagine significantly increased the percentage of orx/hcrt neurons expressing c-Fos compared with either vehicle or leucine ( Figures 3E and 3F ).
Mechanisms of Amino Acid Sensing: Membrane Pathways
To explore the mechanisms of membrane excitation induced by the nutritionally relevant AA mix (Figure 1) , we next performed whole-cell voltage-clamp recordings. Examining membrane current-voltage relationships before and during stimulation with the physiological AA mix showed that AAs suppressed a current with a reversal potential of À99.2 ± 7.1 mV ( Figure 4A ), suggesting a closure of K + channels (E K = -107.6 mV with our solutions). We reasoned that ATP-sensitive K + channels (K ATP ) are attractive candidates since they are closed by increased intracellular ATP (Ashcroft, 1988) . Indeed, blocking K ATP channels with tolbutamide substantially diminished AA-induced depolarization and current (Figures 4B and 4D) . However, some membrane depolarization remained ( Figure 4B ), suggesting additional, tolbutamide-insensitive, mechanism(s). To explore these additional pathways, we examined the biophysical and pharmacological properties of AA responses in the presence of tolbutamide. Under these conditions, AAs activated a net inward current, which did not reverse within the membrane potential range we examined ( Figure 4B ). Because such current-voltage characteristics resemble those of electrogenic amino acid transporters, whose activity depolarizes cell membranes due to cotransport of Na + ions (Mackenzie and Erickson, 2004; Mackenzie et al., 2003) , we tested the effects of different blockers of these membrane transporters. The excitatory amino acid transporter blocker TBOA did not affect the tolbutamide-insensitive remnant of the AA response ( Figure 4D ). In contrast, the system-A transporter inhibitor meAIB completely abolished it ( Figures 4C and 4D ). Together, these data imply that membrane depolarization induced by AAs is explained by a decrease in hyperpolarizing activity of tolbutamide-sensitive K ATP channels and a concurrent increase in the depolarizing activity of meAIB-sensitive system-A transporters.
Mechanisms of Amino Acid Sensing: Intracellular Pathways
We next examined the intracellular signaling pathways involved in AA sensing. We focused on ATP-generating pathways potentially coupled to K ATP channels, and on mTOR-requiring pathways, which may mediate AA sensing in other hypothalamic regions (Cota et al., 2006) . Suppressing mitochondrial ATP production with 2 mM oligomycin reduced, but did not abolish, the effect of AAs on the membrane potential and current (Figures 5A and 5C) . The current-voltage relationship of the oligomycininsensitive component of the AA response ( Figure 5A ) was similar to the tolbutamide-insensitive component ( Figure 4B ), suggesting that the two drugs block the same part of the response. The simplest explanation for this is that mitochondria-derived ATP is required to drive the K ATP -dependent component of the AA response. In contrast, blocking mTOR activity with 1 mM rapamycin did not affect AA-induced depolarization or current (n = 5, Figure 5B ,C), suggesting that mTOR is not critical for AA sensing in orx/hcrt neurons, consistent with the lack of effect of leucine (an mTOR stimulator) on orx/hcrt cells ( Figures 3C, 3E , and 3F).
Effects of Combinations of Amino Acids and Glucose
There is evidence suggesting that brain levels of both glucose and AAs may rise after a meal (Choi et al., 1999 (Choi et al., , 2000 Silver and Ereci nska, 1994) . We therefore examined the effects of simultaneous application of glucose and AAs. We expected that when AAs and glucose are applied together, the two responses would either cancel out or produce a net inhibition because the inhibitory current induced by glucose (e.g., see Figure 7A) was generally larger than the excitatory current induced by AAs (e.g., see Figure 4A ). Surprisingly, application of AAs mixed with concentrations of glucose that were similar or greater than maximal physiological levels in the brain (5-10 mM glucose, see Routh, 2002) produced potent depolarization and excitation, even though glucose alone produced its typical hyperpolarization on the same cell ( Figure 6A ). The depolarizing direction of these responses persisted even when the AA concentration in the combined stimulus was reduced 2-or 4-fold ( Figure 6B ).
(D) Effect of ''AA mix'' on non-orx/hcrt lateral hypothalamic neurons expressing GAD65 (n = 7, see Experimental Procedures). Membrane potential during AA application (À46.6 ± 1.2 mV) was not different from preapplication (À48.8 ± 1.0 mV, p > 0.15) or postapplication (À47.5 ± 1.7 mV, p > 0.6). (E) Effect of ''AA mix'' on neurons from secondary somatosensory cortex layer 2-4 (n = 7). Membrane potential during AA application (À49.1 ± 0.8 mV) was not different from preapplication (À49.6 ± 0.6 mV, p > 0.3) or postapplication (À48.8 ± 1.1 mV, p > 0.8).
(F) Depolarization (means ± SEM) caused by the AA mix in different conditions, evoked from the same baseline of À50 mV (*** = p < 0.001; n.s. = p = 0.24). (G) Left, effect of switching from ''low AA mix'' to ''AA mix'' (see Table S1 ) on orx/hcrt cells (n = 6, quantified in F). Right, dose-response (means ± SEM) of AAinduced depolarization. Total concentration of AA mix was changed while proportions of AAs were kept same as in ''AA mix'' in Table S1 . EC 50 value (see Experimental Procedures) = 438.2 mM (equivalent to 0.66-fold of ''AA mix'' in Table S1 ). (H) Effects of AAs in cell-attached recording mode (left, frequency histogram; right, raw trace, n = 6). Firing rate was higher in AA (6.6 ± 0.5 Hz) than in low AA (3.0 ± 0.3 Hz, p < 0.001). Thus during simultaneous application glucose and AA effects do not sum linearly, but become biased toward the AA response. Indeed, during coapplication of glucose and AAs, the net change in membrane current resembled that caused by AAs alone ( Figures 6C and 6D) .
To examine whether this is because the AAs influence the glucose response, we looked at glucose responses with and without AAs in the bath solution. We found that glucose-activated current was significantly suppressed ($3-to 4-fold) in the presence of AAs, for both large (1 / 5 mM) and small (0.5 / 2.5 mM) changes in [glucose] ( Figure 7A ). To investigate whether changes in intracellular energy metabolism could be involved in such changes in glucose response magnitude, we next examined glucose responses in the presence of different concentrations of extracellular pyruvate. This is expected to mimic the effects of AAs downstream of system-A transporters, because (1) the catabolic pathways of many AAs involve pyruvate production (Stryer, 1999) , and (2) exogenously applied pyruvate is able to enter neurons, increase ATP levels, and drive ATP-dependent processes (Cruz et al., 2001; Tarasenko et al., 2006) . We found that pyruvate dose-dependently reduced the magnitude of glucose-activated current ( Figure 7B ).
The suppression of glucose response by AAs presumably accounts for the excitatory response seen when AAs and glucose are applied simultaneously (Figure 6 ), or when AAs are applied on the background of elevated glucose ( Figure 7C ). However, consistent with the observation that the glucose current was not completely blocked by physiological levels The same baseline potential of -50 mV was imposed by sustained current injection. eAAs produced 3.2 ± 1.0 mV depolarization, nAAs produced 9.0 ± 1.5 mV depolarization, n = 4 for each, p < 0.01. Bottom, effect of mixes of physiological concentrations of nAAs (physiol-nAAs) and eAAs (physioleAAs) on membrane potential studied in the same cell (n = 7). The same prestimulation potential of -50 mV was imposed by sustained current injection. nAAs produced 6.0 ± 0.5 mV depolarization (significantly greater than zero, p < 0.0001), eAAs produced 1.8 ± 0.8 mV depolarization (not significantly greater than zero, p > 0.05); nAA effect was significantly larger than eAA (p < 0.002). of AAs ( Figure 7A ), applying glucose on the background of pre-elevated AAs still produced consistent hyperpolarizing responses ( Figure 7D ). Thus, during sequential application of glucose and AAs, different responses may be produced depending on the relative order of the two stimuli.
Effects of Fatty Acids
In addition to glucose and amino acids, the third major group of macronutrients that are sensed by the brain as signals of energy status are fatty acids (Lam et al., 2005) . We examined the effects of a mixture of three common fatty acids (FA mix, composition given in Experimental Procedures), which were previously reported to modulate firing of neurochemically undefined hypothalamic neurons (Oomura et al., 1975; Wang et al., 2006) . To elicit maximum responses, our FA mix contained higher FA concentrations than those reported in the brain in vivo (Phillis et al., 1999) . We found no evidence for FA-elicited changes in membrane potential or voltage ramps ( Figures 8A and 8B , n = 7). We also carried out cell-attached recordings while applying a 3x concentrated FA mix. Firing frequency did not change significantly during FA application (baseline firing rate, 4.0 ± 0.5 Hz; during FA application, 4.8 ± 1.2 Hz; n = 4; p = 0.48; data not shown). Furthermore, coapplication of FAs with either 5 mM glucose (n = 4) or AA mix (n = 5) or both (n = 5) did not change the typical responses to these nutrient mixtures ( Figure 8C ). This suggests that under our experimental conditions, FAs do not directly modulate the firing of orx/hcrt cells.
DISCUSSION
Actions of Dietary Amino Acids on orx/hcrt Circuits
Despite the importance of dietary timing and composition for healthy body weight and sleep-wake cycles (Flier, 2004; Kohsaka et al., 2007) , the effects of typical dietary nutrient mixtures on specific neurons regulating metabolic health are poorly understood. Our study uncovers several features of macronutrient interactions with cells that act as key regulators of energy balance. First, the orx/hcrt cells were directly stimulated by nutritionally relevant mixtures of dietary AA mixtures, both in vitro (Figure 1 ) and in vivo (Figures 2A and 2B ). Peripheral administration of AAs produced locomotor effects consistent with orx/hcrt release ( Figure 2C) . Second, our data show that the stimulatory effects of AAs on orx/hcrt cell membrane involve an increase in the depolarizing activity of system-A AA transporters, and a concurrent reduction in the hyperpolarizing The net current (bottom right graph) was calculated as current during AA stimulation minus current before AA stimulation (i.e., AAs-activated current) (n = 12). (C) Same experiment as in (B), but in the presence of 300 mM tolbutamide and 10 mM meAIB (n = 11). (D) Quantification of membrane depolarization (means ± SEM) in the presence and absence of drugs (n = 25 for control, 9 for Tb, 5 for Tb+TBOA, 9 for Tb+meAIB). *** = p < 0.001, n.s. = not significant (p > 0.3). activity of K ATP channels (Figures 4 and 5) . Consistent with the involvement of the system-A transporters, which prefer nonessential AAs (Mackenzie and Erickson, 2004) , orx/hcrt cells were more potently stimulated by nonessential AAs in vitro and in vivo (Figure 3) . Third, the excitatory influence of AAs on orx/hcrt cells summed nonlinearly with the previously reported inhibitory effect of glucose, in favor of AA excitation ( Figure 6 ). This is probably due to the suppression of the glucose response by AAs, and/or their metabolic derivatives (Figure 6 ). Because physiological AA fluctuations in the brain occur within a smaller concentration range than those of glucose (Choi et al., 1999 (Choi et al., , 2000 Silver and Ereci nska, 1994) , it is possible that the suppression of glucose response by AAs may serve to amplify the relative influence of AAs on the orx/hcrt neurons.
Implications for Sensing of Macronutrient Balance
Recently, two hypotheses were proposed to explain how the AA composition of the extracellular space could be converted into appropriate changes in brain activity. One envisages sensing of essential AAs by deacylated tRNA in the piriform cortex, based on the observation that blocking tRNA synthetases of essential AAs in this region induces feeding behavior similar to that caused by essential AA deficiency (Hao et al., 2005) . Another hypothesis involves sensing of leucine (an essential AA) by an mTOR-related pathway in the mediobasal hypothalamus (Blouet et al., 2009; Cota et al., 2006) . Both of these mechanisms are selective for essential AAs, unlike the mechanism described in our study, which is more sensitive to nonessential AAs. In terms of body function, essential AA levels may seem to be more critical to detect, because they cannot be made in the body and thus have to be obtained through foraging. However, it is noteworthy that essential and nonessential AAs can compete with each other for entry through the blood-brain barrier (Oldendorf and Szabo, 1976) , and thus a rise in nonessential AA levels in the brain may signal a fall in essential AA levels in the blood. Another physiological situation that may, potentially, benefit from increased stimulation of orx/hcrt neurons by AAs is prolonged starvation, where a rise in extracellular AA levels occurs as proteins are broken down to AAs for fuel (Adibi, 1968; Felig et al., 1969) .
More fundamentally, our data suggest that orx/hcrt neurons are under ''push-pull'' control by glucose and AAs, and that nutrient mixtures dominated by glucose would suppress the orx/hcrt system, while nutrient mixtures dominated by AAs would increase its activity. Interestingly, there is accumulating evidence that underactivity and overactivity of the orx/hcrt system may lead to depression and anxiety, respectively (Boutrel et al., 2005; Brundin et al., 2007; Ito et al., 2008; Suzuki et al., 2005) . While a definitive investigation of behavioral effects is beyond the scope of the present study, it is noteworthy that some existing psychological analyses are consistent with our cellular data. For example, protein-rich meals have been reported to be more effective at promoting cognitive arousal than carbohydrate-rich meals (Fischer et al., 2002; Spring et al., 1982 Spring et al., -1983 .
In summary, our data show that the activity in the orx/hcrt system is regulated by macronutrient balance, rather than simply by the caloric content of the diet. We propose that the distinct effects of different macronutrients on orx/hcrt cells may allow these neurons to translate different diets into different patterns of activity in their widespread projection targets.
EXPERIMENTAL PROCEDURES Electrophysiological Recordings in Acute Mouse Brain Slices Preparation of Living Brain Tissue
Animal procedures were performed according to the Animals (Scientific Procedures) Act, 1986 (UK). Transgenic orx/hcrt-eGFP mice were used to identify and study orx/hcrt neurons in electrophysiological experiments, as previously described (Williams et al., 2007 (Williams et al., , 2008 . These mice express eGFP under the control of the prepro-orexin promoter, resulting in highly specific targeting of eGFP only to orx/hcrt cells (Burdakov et al., 2006; Yamanaka et al., 2003) .
For lateral hypothalamic control experiments shown in Figure 1D , we used GAD65-GFP mice, which were of C57BL/6 background and expressed GFP gene fused to the first or third exon of the GAD65 gene; these mice express GFP exclusively in GABAergic GAD65-containing neurons, as previously characterized (Bali et al., 2005; Ló pez-Bendito et al., 2004) .
Mice were maintained on a 12 hr light:dark cycle (lights on at 0800 hr) and had free access to food and water. Coronal slices (250 mm thick) containing the lateral hypothalamus were prepared from 13-to 29-day-old animals. Experiments in Figures 1G, 7C , and 7D were replicated in adult mice (37-64 days old). Mice were killed by cervical dislocation during the light phase and rapidly decapitated. Brains were quickly removed and placed into ice-cold sectioning solution. A block of brain tissue was glued to the stage of a Campden Vibroslice for slicing while immersed in ice-cold sectioning solution. After a 1 hr recovery period at 35 C in ACSF, slices were used for recordings within $8 hr.
Basic Solutions ACSF was continuously gassed with 95% O 2 and 5% CO 2 and contained (in mM): 125 NaCl, 2.5 KCl, 2 MgCl 2 , 2 CaCl 2 , 1.2 NaH 2 PO 4 , 21 NaHCO 3 , and 1 glucose (except where indicated otherwise). Sectioning solution contained (in mM): 95 NaCl, 1.8 KCl, 1.2 CaCl 2 , 26 NaHCO 3 , 1.2 KH 2 PO 4 , 7 MgSO 4 , 50 sucrose, and 15 glucose. Two types of intracellular (pipette) solutions were used. ''High-Cl'' pipette solution contained (in mM): 130 KCl, 0.1 EGTA, 10 HEPES, 5 K 2 ATP, 1 NaCl, 2 MgCl 2 (pH 7.3) with KOH. ''LowCl'' pipette solution contained (in mM): 120 K-gluconate, 10 KCl, 0.1 EGTA, 10 HEPES, 5 K 2 ATP, 1 NaCl, 2 MgCl 2 (pH 7.3) with KOH. Liquid junction potential for the low-Cl solution was estimated to be 10 mV and has not been subtracted from the measurements. The low-Cl solution, which mimics the ionic composition in a typical central neuron, was used in all experiments except those in Figures 3A-3C (where we used high-Cl solution) and Figure 1H (where we used ACSF).
Nutrient Mixtures
All AAs used were L-isoforms and glucose was D-(+)-glucose. The concentrations of AAs in the control and ''low'' AA mixes are given in Table S1 Figure 8. Effect of Fatty Acids on orx/hcrt Neurons (A) Effects of FAs on the membrane potential, n = 8. In FA, the membrane potential was À49 ± 2 mV; not different from baseline (À46 ± 2 mV, n = 5, p > 0.1) or washout (À47.1 ± 1.1 mV, n = 5, p > 0.3).
(B) Effects of FAs on the membrane current (shown as net FA-activated current, means in black and SEM in gray), n = 7. (C) Effects of coapplying FAs with either glucose (G, n = 4), AAs (n = 5), or both (n = 5). The amplitudes of responses with FAs did not differ from those without FAs: FA+AA, 11.7 ± 2.1 mV depolarization v AA, 12.6 ± 0.7 (p > 0.5, n = 5 and 25, respectively); FA+glucose, 15.1 ± 2.1 mV hyperpolarization v glucose, 18.2 ± 1.0 mV (p > 0.18, n = 4 and 5, respectively); FA+AA+glucose, 12.0 ± 2.0 mV depolarization v AA+glucose, 10.5 ± 0. 9 mV (p > 0.5, n = 5 for both).
(called ''AA mix'' and ''low AA mix,'' respectively). Purity of the AA mix was examined by ion-exchange chromatography followed by ninhydrin analysis (Department of Biochemistry Analytical Facility, University of Cambridge), where threshold for detection was 0.5 mM. No GABA or glutamate contamination was detected and glycine concentration was within 10% of the intended value. Classification of amino acids as essential or nonessential in Figure 3B was based on Gietzen and Rogers (2006) . In the upper panel of Figure 3D , we omitted cysteine because it is toxic and not found in CSF (Choi et al., 1999; Nishimura et al., 1995) , glutamate to avoid excitation through glutamate receptors, and glycine because at high concentrations it may modulate orx/hcrt neurons through glycine receptors (Karnani et al., 2010) . In the upper panel of Figure 3D , other AAs listed in Table S1 were present in 100 mM concentration making the total concentration for essential AA mix 1.1 mM, and nonessential AA mix 0.6 mM. In the lower panel of Figure 3D , the concentrations for AAs were from ''AA mix'' in Table S1 . ''FA mix'' contained (in mM): 5 oleic acid, 5.4 palmitic acid, and 1.8 palmitoleic acid (Oomura et al., 1975; Wang et al., 2006) .
Drugs
The following drugs were added to the extracellular solution where indicated: 50 mM (2R)-amino-5-phosphonovaleric acid (AP5), 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), 10 mM dizocilpine maleate (MK801), 50 mM picrotoxin (PiTX), 200 mM DL-threo-b-Benzyloxyaspartic acid (TBOA), 3 mM strychnine, 1 mM rapamycin, 2 mM oligomycin and 10 mM N-(methylamino)isobutyric acid (MeAIB), 0.5 mM tetrodotoxin. All drugs were obtained from Sigma or Tocris (UK). Chemicals were applied extracellularly by bath superfusion.
Recording and Analysis
Living neurons expressing eGFP were visualized in brain slices using an Olympus BX50WI upright microscope equipped with oblique illumination optics, a mercury lamp, and eGFP excitation and emission filters. Somatic recordings were carried out at 37 C using an EPC 10 patch-clamp amplifier (HEKA Elektronik, Germany). Patch pipettes were made from borosilicate glass, and their tip-resistances ranged from 3 to 8 MU (3-5 MU with high-Cl and 5-8 MU with low-Cl pipette solution). Slices were placed in a submerged-type chamber (volume $2 ml, solution flow rate 2.5 ml/min) and anchored with a nylon string grid. Only cells with access resistances between 10 and 25 MU were accepted for analysis. In experiments where change in membrane potential was quantified, all cells were initially held at the same potential to facilitate comparison (À50 mV when depolarization was quantified, and À40 mV when hyperpolarization was quantified), by applying a fixed holding current throughout experiment. Data were sampled and filtered using Pulse and Patchmaster software (HEKA Elektronik, Germany). Current-voltage (I-V) relationships were obtained by performing voltage-clamp ramps from À20 to À130 mV at a rate of 0.1 mV/ms ramp, which is sufficiently slow to allow leak-like K + currents to reach steady state at each potential (Meuth et al., 2003) . In cell-attached mode ( Figure 1H ), the patch pipette was filled with ACSF and action potential frequency was measured in voltage-clamp at a command potential under which the holding current is 0 pA (Perkins, 2006) . Breaks in some current-clamp traces correspond to moments when the recording was paused (e.g., to take voltage-clamp measurements or inject cell with current for measurement of input resistance). In some current-clamp experiments (e.g., Figures 1D and 4A ) the cells were periodically injected with hyperpolarizing current pulses to monitor membrane resistance. Statistical analyses were performed using Origin (Microcal, Northampton, MA) and Microsoft Excel (Microsoft, Redmond, WA) software. Averaged data are presented as mean ± SEM. Statistical significance was tested using the Student's t test unless indicated otherwise.
The following modified Hill equation was fitted to the data in Figures 1G  and 3C :
where R max is the maximal change in membrane potential, EC 50 is the concentration that gives half-maximal response, and h is the Hill coefficient. The fit shown in Figure 1G was obtained with R max = 20.4 mV, h = 1.79 and EC 50 = 438.2 mM. The fit shown in Figure 3C was obtained with R max = 950.6 pA, h = 2.39, and EC 50 = 3.19 mM.
Assays of orx/hcrt Activity after Peripheral Administration of Amino Acids Intragastric Gavage Subjects were 14-week-old C57BL/6 male mice (Charles River). The mice were maintained on a standard 12 hr light-dark cycle (lights on at 0700 hr).
Mice were acclimatized to the gavage procedure for 2 weeks by daily sham gavage. Food was available ad libitum, but to avoid large between-animal variations in metabolic state, mice were fasted throughout the experiment, starting 2 hr (at 1700 hr) prior to gavage (1900 hr). Animals were then given either vehicle gavage (0.4 ml deionized water) or AA gavage (0.4 ml of AAs dissolved in deionized water, at concentrations described in Table 1 of Choi et al., 1999) . Immunocytochemistry Three hours after gavage of AA or vehicle solutions (four animals per group), the animals were anesthetized with ketamine (100 mg/kg i.p), and transcardially perfused with diethylpyrocarbonate (DEPC)-treated 0.9% saline followed by phosphate-buffered 10% formalin. Hypothalamic sections (30 mm) were pretreated in 0.6% H 2 O 2 and washed three times with 0.1 M PBS. Following a 1 hr incubation in blocking solution (1% BSA in 0.1 M PBS and 0.25% Triton X-100), tissue was gently shaken overnight (4 C) in 0.1 M PBS with rabbit anti-c-Fos (Calbiochem; Nottingham, UK) and goat anti-orexin (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies (1:10,000; 1:1000; respectively). On Day 2, tissue was rinsed in 0.1 M PBS and incubated with secondary antibodies against rabbit (Biotinylated; 1:1000; Stratech; Newmarket Suffolk, UK; shown in red pseudocolor in Figure 2A ) and goat (Alexa 488, 1:1000; Paisley, UK; shown in green in Figure 2A ) in blocking solution for 2 hr. Next, tissue was shaken in a standard ABC mixture (Vector Labs; Peterborough, UK) for 1 hr and then processed using a 3,3 0 -Diaminobenzidine (DAB) kit (Vector Labs; Peterborough, UK). Tissue was finally washed in 0.1 M PBS, mounted onto slides and coverslipped. Quantification of the proportion of c-Fos-positive orx/hcrt neurons was performed by an investigator blind to the experimental conditions, using four to six sections per animal in the bregma range À1.88 to À1.06 mm, as described in our previous study (Williams et al., 2011) . Locomotor Activity Assay Mouse locomotor activity was measured in the x-dimension using a beambreak monitor in the Comprehensive Lab Animal Monitoring System (CLAMS, Columbus Instruments) at the animal core facility of the Institute of Metabolic Science, University of Cambridge. Note that measuring the effect of AA gavage on locomotion itself unavoidably produces increased orx/hcrt release. Specifically, this would be caused by the necessary prefasting (which increases orx/hcrt activity, Cai et al., 2001; Komaki et al., 2001) , the stress and wakefulness induced by gavage in mice (orx/hcrt cells are stress-stimulated, Winsky-Sommerer et al., 2004) , and the circadian phase used to measure locomotion (during which the endogenous activity of orx/hcrt cells is likely to be high (Estabrooke et al., 2001; Kiyashchenko et al., 2002; Mileykovskiy et al., 2005) . As expected from such effects, our control experiments (see Figure S1 ) indicated that under these conditions, AA gavage described in (Choi et al., 1999) does not significantly elevate the already-high locomotor activity, consistent with a ''ceiling'' effect. To reduce the background occupancy of orx/hcrt receptors, we thus treated the animals with the competitive orx/hcrt receptor antagonist SB-334867 (given i.p. at the same time as gavage). This antagonist has a higher affinity for OX1/HCRTR1 receptor than for OX2/HCRTR2 receptor, but at higher concentrations antagonizes orx/hcrt binding to both receptor subtypes (Smart et al., 2001 ). We used a single high dose of SB-334867 of 30 mg/kg, based on previous studies with this compound (Adamantidis et al., 2007; Haynes et al., 2000 Haynes et al., , 2002 Rodgers et al., 2001) . Eight mice per group were used, which were put into the beam-break cages at 0900 hr (10 hr before gavage). AA or vehicle gavage was performed as described above. SB-334867 (in vehicle, 0.9% NaCl 10% DMSO), or vehicle alone, was injected i.p. (injected volume = 10 ml/g) at the same time as gavage. Total x axis locomotor activity was grouped in 2 hr bins.
Assays of orx/hcrt Activity after Central Administration of Amino Acids Intrahypothalamic Infusions
Mice were housed in individual Plexiglas recording cages in temperature (22 C ± 1 C) and humidity (40%-60%) controlled recording chambers (custom-designed stainless steel cabinets with individual ventilated compartments) under a 12 hr/12 hr light/dark cycle (lights on at 0700 hr). Food and water were available ad libitum. Animals were implanted with a 26G bilateral cannula (Plastics One) under ketamine/xylazine anesthesia (80 and 16 mg/kg, i.p., respectively). The cannula was placed above the lateral hypothalamus (anteroposterior, 1.8 mm; mediolateral, 0.8 mm; dorsoventral; 4.5 mm) according to the brain atlas (Franklin and Paxinos, 2008) and affixed to the skull with C&B metabond (Parkell, Edgewood, NY) and dental acrylic. Mice were allowed to recover for 10 days and were then habituated for 5 days to infusion procedure before the experiment. On the day of experiment, animals were connected to an internal bilateral cannula. At 1000 hr, vehicle was infused in the left part of the brain while either L-leucine (5 mM) or L-asparagine (5 mM) was infused in the right part of the brain in two separate experiments. In each condition, a total volume of 0.5 ml was injected through the cannula at a rate of 0.25 ml/min. Internal cannula was maintained in place for one additional minute to allow liquid diffusion through the brain tissue. Animals were sacrificed 1 hr after the infusion protocol for immunohistochemistry tissue processing.
Immunocytochemistry
We quantified the activation of orx/hcrt neurons after intrahypothalamic infusions of AA using double immunostaining for c-Fos and orx/hcrt. The double immunostaining was performed on brain sections from wild-type animals as previously described (Adamantidis et al., 2007) . Briefly, mice (n = 4 per condition) were anesthetized with xylazine/ketamine and perfused transcardially with physiological saline followed by 4% paraformaldehyde in phosphatebuffered saline (PBS; pH 7.4), 1 hr after vehicle or AA infusion. Brains were postfixed and cryoprotected. Coronal brain sections containing the lateral hypothalamus were successively incubated in (1) a rabbit antiserum to c-Fos (1:5000, Calbiochem) in PBS supplemented with 0.3% Triton X-100 (PBST) and 4% bovine serum albumin (BSA, Sigma) for 1 day at 4 C; (2) a biotinylated antirabbit IgG solution (1:1000, Vector Laboratories) in PBST; and (3) an ABCperoxidase solution (1:1000, Vector Laboratories) both for 60 min at room temperature. Finally, sections were stained using 3,3 0 -diaminobenzidine-4
HCl and Nickel solution (DAB-Ni; Vector Laboratories) in order to obtain dark purple staining. Four washes in PBST were performed between each step. The c-Fos-stained sections were incubated in a goat antiserum to orx/hcrt (1:4000; Santa Cruz) in PBST/BSA 4% for 2 days at 4 C. Amplification steps were similar to those described above but the final step was performed in DAB solution without nickel in order to obtain brown staining. Finally, the sections were mounted on slides, dried, and coverslipped with permaslip. Orx/hcrt-positive and orx/hcrt+c-Fos-positive neurons were counted by an investigator blind to experimental conditions, within at least six coronal sections per animal evenly spaced throughout the rostrocaudal extent of the lateral hypothalamus (Bregma À1.06 to À2.14) to avoid rostrocaudal bias. Colocalization of c-Fos and orx/hcrt immunostaining was detected using a high magnification objective. No significant differences were found in the number of c-Fos-positive orx/hcrt neurons between vehicle injection experiments.
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